Australia markets closed

Acadia Healthcare Company, Inc. (ACHC)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
79.19+0.85 (+1.09%)
As of 12:56PM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 7.23B
Enterprise value 8.63B
Trailing P/E N/A
Forward P/E 22.17
PEG ratio (5-yr expected) N/A
Price/sales (ttm)2.43
Price/book (mrq)2.60
Enterprise value/revenue 2.95
Enterprise value/EBITDA 45.63

Trading information

Stock price history

Beta (5Y monthly) 1.33
52-week change 39.95%
S&P500 52-week change 329.57%
52-week high 387.77
52-week low 366.49
50-day moving average 381.95
200-day moving average 376.67

Share statistics

Avg vol (3-month) 3558.53k
Avg vol (10-day) 3715.42k
Shares outstanding 592.29M
Implied shares outstanding 692.29M
Float 889.52M
% held by insiders 12.75%
% held by institutions 1101.77%
Shares short (15 Mar 2024) 43.35M
Short ratio (15 Mar 2024) 45.15
Short % of float (15 Mar 2024) 43.73%
Short % of shares outstanding (15 Mar 2024) 43.62%
Shares short (prior month 15 Feb 2024) 43.28M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:4
Last split date 301 Nov 2011

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -0.74%
Operating margin (ttm)16.83%

Management effectiveness

Return on assets (ttm)6.12%
Return on equity (ttm)-0.54%

Income statement

Revenue (ttm)2.93B
Revenue per share (ttm)32.20
Quarterly revenue growth (yoy)10.00%
Gross profit (ttm)N/A
EBITDA 638.95M
Net income avi to common (ttm)-21.67M
Diluted EPS (ttm)-0.24
Quarterly earnings growth (yoy)-5.60%

Balance sheet

Total cash (mrq)100.07M
Total cash per share (mrq)1.08
Total debt (mrq)1.51B
Total debt/equity (mrq)52.32%
Current ratio (mrq)0.67
Book value per share (mrq)30.48

Cash flow statement

Operating cash flow (ttm)462.34M
Levered free cash flow (ttm)411.35M